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Abstract This study had two objectives: to describe the his-
torical development of self-reported presenteeism instruments
that can be used to identify and measure presenteeism as a
result of musculoskeletal disease (MSD) and to identify if,
and how many of these, presenteeism instruments are
underpinned by economic theory. Systematic search methods
were applied to identify self-report instruments used to quan-
tify presenteeism caused by MSD. A total of 24 self-reported
presenteeism instruments were identified; 24 were designed
for use in general health, and 1 was specifically designed for
use in rheumatoid arthritis. One generic self-reported
presenteeism instrument was explicitly reported to be
underpinned by economic theory. Overtime, self-reported
presenteeism instruments have become more differentiated
and complex by incorporating many different contextual fac-
tors that may impact levels of presenteeism. Researchers are
encouraged to further develop presenteeism instruments that
are underpinned by relevant economic theory and informed by
robust empirical research.
Keywords Systematic review . Self-report presenteeism
instruments . Musculoskeletal diseases . Economic theory
Introduction
Since 1990, the global burden of musculoskeletal diseases
(MSDs), including chronic rheumatological conditions, as
measured by disability-adjusted life years (DALYs), has been
shown to increase dramatically [1]. For many chronic rheu-
matological conditions, such as rheumatoid arthritis (RA),
psoriatic arthritis (PsA) and ankylosing spondylitis (AS), dis-
ease onset can occur at any age; however, peak incidence rates
have been found to occur between the ages of 40 and 65 years
[2]. Previous reviews have estimated that within 13 years after
onset RA, the probability of becoming work-disabled is 50 %
[3, 4]. Similarly, after 5 years of the onset of AS, up to 13% of
adults are likely to lose their jobs [5]. The reduction in health
status in people with these diseases will not only affect their
daily functioning, and cause early mortality, but may also have
a major impact on their productivity at work (productivity
loss). In the last two decades, there have been some advances
in the treatment of MSD, but these strategies are not curative
and many people still experience productivity loss [6–8].
Productivity can be viewed, within the context of the em-
ployment environment, as a measure of technical efficiency
that examines how inputs, such as labour and capital (technol-
ogy), are used to produce outputs of sufficient volume and
quality [9]. The productive rate of any individual may be
affected by a variety of factors such as job demands, levels
of support, working hours, job satisfaction and, perhaps most
importantly, poor health. The impact of a reduction in health
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status has been directly linked to productivity loss through
absenteeism and presenteeism. Absenteeism refers to the time
(hours, days, weeks) spent away from work because of illness
[10–13], and presenteeism refers to the reduction in ‘working
performance whilst at work due to ill health’ [14].
It is relatively easy to objectively quantify absenteeism using
simple counts of days away from work. Quantifying the impact
of presenteeism is much more challenging, involving two
stages: (1) identifying and measuring the volume of unproduc-
tive time and (2) valuing the impact of that unproductive time.
The lack of available objective measures that can be used to
identify and measure presenteeism has led to the development
of instruments that rely on self-reports from the individual af-
fected by an adverse health condition, such as a MSD.
A number of reviews have systematically identified a num-
ber of instruments, both general health and disease-specific,
that are available to self-report presenteeism. Some of these
systematic reviews have focused on how to identify and mea-
sure presenteeism and found that the available instruments
differed extensively and lead to vastly different estimations
of the volume of presenteeism [11, 15, 16]. In contrast, the
methods used to value the impact of presenteeism has largely
focused on using two, similar, methods that centre on using
cost as the unit of measurement: the human capital approach
(HCA) and the friction cost approach (FCA) [17]. The HCA
and FCAvalue the amount of productivity loss by multiplying
the amount of time an individual is unproductive during a
working week by the wage rate. The two methods differ in
terms of the perspective they take. The HCA calculates the
cost of lost productivity from the perspective of the patient/
employee. Therefore, the cost of lost productivity continues
until that individual employee/patient has found another job.
The FCA takes an employer perspective and calculates the
cost of lost productivity based on the amount of time it takes
to replace the sick employee; this period of time is known as
the ‘friction’ period. Once the sick employee has been re-
placed, the FCA assumes that initial production levels are
restored [17]. The HCA and the FCA are grounded in eco-
nomic theory that assumes that productivity is equal to the
market wage which represents the marginal revenue prod-
uct of labour of an employee working for an employer in
the context of a perfectly competitive market [18]. Two
studies by Pauly et al. [19] and Zhang et al. [12] criticise
the economic theories that are used to underpin methods
that value the cost of lost productivity. Pauly et al. sug-
gested that the allowances for sick days and protection
against fluctuating wages will mean that employees will
accept a wage rate that is lower than the value of the
marginal productivity of the worker. Therefore, the value
of productivity loss will exceed the value of the wage
because the wage is lower than marginal productivity.
Similarly, Zhang et al. argued that the cost of productivity
loss will exceed the value of the wage rate if a job
involved team-based work, unavailability of substitutes,
and produces highly time-sensitive output.
It is important to understand the theoretical underpinning of
an approach to quantify the impact of a subjective construct,
such as presenteeism, to enable the development of a robust
approach to its identification, measurement and valuation.
Economic theories provide a common framework from which
to develop methods that can be used to identify and measure
the impact of presenteeism. To our knowledge, it is currently
unknown which, if any, self-reported presenteeism instrument
used to identify and measure presenteeism is underpinned by
economic theory. This study had two objectives: (1) to de-
scribe the historical development of self-reported instruments
that can be used to identify and measure presenteeism as a
result of a MSD and (2) to identify if, and how many of these,
self-reported presenteeism instruments are underpinned by
economic theory.
Methods
A systematic review was carried out to identify all published
studies that describe the development of self-reported
presenteeism instruments that can be used inMSD. The search
was run up until November 2015. The systematic review was
conducted, in line with advice and guidelines published by the
Centre for Reviews and Dissemination (CRD) [20] and
followed the Preferred Reporting Items for Systematic
Reviews and Meta-Analyses (PRISMA) checklist.
Search Strategy
The search for relevant studies involved updating a recent
systematic search conducted by Ospina et al. in 2012 [21•].
Ospina et al. conducted a systematic search that identified all
general health and disease-specific presenteeism instruments.
The electronic search strategies used by Ospina et al. (see
Appendix) were retrieved and re-ran in eight electronic data-
bases including Medline (1946 to September week 3 2015),
Embase (1980 to week 40 2015), Cochrane Central Register
of Controlled Trials (CENTRAL) (August 2015), PsychINFO
(1806 to September week 4 2015), Web of Science (1900 to
November 6, 2015), CINAHL (1937 to November 6, 2015),
Business Source Complete (1886 to November 6, 2015) and
ABI inform (1970 to November 6, 2015). The electronic
search strategies comprised of the specific names of
presenteeism instruments, such as the ‘Endicott work produc-
tivity scale’ and more generic terms such as ‘productivity’ and
‘presenteeism’. The new search was constrained to run be-
tween 1st January, 2012 to 6th November, 2015.
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Study Selection Process
All titles and abstracts identified were double screened for
inclusion by two independent reviewers (CJ and either KP,
BG or SV) and accepted if the study met the inclusion criteria
specified in Table 1.
Data Extraction and Synthesis
One reviewer (CJ) extracted the data from each study using a
bespoke data collection form to extract author, year and coun-
try that the study was completed; name of the presenteeism
instrument; aims of the instrument; whether the instrument
also measured absenteeism; the structure of the instrument;
recall period used; whether estimations of presenteeism using
that specific instrument could be converted into monetary
values using the HCA or FCA; and clear reporting of the
economic theories used to underpin the presenteeism instru-
ment developed. The results were tabulated and summarised
as part of a narrative synthesis.
Results
In total, 24 studies that described the development of
presenteeism instruments for use in MSD were identified. Of
these, the Work Productivity Survey for Rheumatoid Arthritis
(WPS-RA) [22] was the only one designed to specifically
measure presenteeism associated with a MSD (RA). The re-
maining 24 presenteeism instruments were developed for use
across a wide range of health conditions, including MSD.
Figure 1 illustrates the identification and inclusion of relevant
studies. A summary of the identified presenteeism instruments
are presented in Table 2.
Self-Reported Presenteeism Instruments: a History
The earliest identified measure of presenteeism, the Work
Performance Scale (WPS), was designed by Jette et al. in 1986
[23]. TheWPS asks the respondent to rate their ability to function
physically, mentally and socially. The measure is simple and
originally designed for clinical use. In 1993, Reilly et al. (1993)
developed the Work Productivity Activity Index (WPAI) which
differs substantially to the WPS. The WPAI asks the respondent
to state the number of days missed fromwork and the number of
days they found work difficult. The instrument also asks about
productivity loss when doing unpaid work.
By the late 90’s and early 2000’s, presenteeism instruments
were being designed to collect additional information regard-
ing the contextual factors of an individual’s occupation. For
example, the Occupational Role Performance Questionnaire
(ORQ) developed by Kopec and Esdaile in 1998 [27] collects
information about the individual’s job satisfaction, job securi-
ty and the quality of the relationships they have with their
colleagues. The Work Instability Scale (WIS) developed by
Gilworth et al. in 2003 [34] asks questions about the respon-
dent’s work situation and physical work factors.
In 2004, Stewart et al. [39] developed the Work Health
Interview (WHI). The WHI is a telephone interview designed
to collect information that can be used to estimate the cost of
productivity loss. The interview introduces questions about
the type of work tasks individuals are expected to complete
as part of their job. TheWHI is one of the first instruments that
explicitly take into account how job characteristics may affect
levels of presenteeism. In 2012, Zhang and colleagues devel-
oped the Valuation of Lost Productivity (VOLP) questionnaire
[43•], a presenteeism instrument that explicitly takes into ac-
count how factors such as team dynamics, availability of per-
fect substitutes and time sensitivity of outputs either compen-
sate or multiply levels of productivity loss caused by health
conditions. Since 2015, presenteeism instruments, including
the Composite Work Functioning Approach [44] and the
Table 1 Inclusion criteria
Inclusion criteria Exclusion criteria
Study type Development of method that quantifies presenteeism Studies that apply the developed method, for example, in economic evaluations
Studies that test methods of presenteeism in terms of their psychometric
properties and do not discuss the development of the instrument
Focus Methods developed for assessing health-related
presenteeism
Methods developed for assessing other forms of productivity loss, e.g. shirking
Methods developed for assessing generic health or
musculoskeletal conditions
Methods developed that focus on disease-specific areas except musculoskeletal
conditions, e.g. mental health
Original development of presenteeism methods Adaptations of methods for use in other countries, e.g. WLQ-J
Adaptations of methods for use in specific disease areas if the original was
developed for general health
Publication
type
English language Foreign languages
Curr Rheumatol Rep (2016) 18: 53 Page 3 of 15 53
iMTA Productivity Cost Questionnaire (iPCQ) [45], have
been developed using questions from pre-existing measures
including the Work Limitations Questionnaire (WLQ) [31],
the Health Limitations Questionnaire (HLQ) [25] and the
Productivity and Disease Questionnaire (PRODISQ) [46]
rather than developing another completely new presenteeism
instrument.
Economic Theory Underpinning Presenteeism
Instruments
Of the 24 studies that report the development of presenteeism
instruments, only one study by Zhang et al. (2012) [43•]
discussed how economic theory was used to underpin the
design of their presenteeism instrument. They explain the eco-
nomic rationale behind the development of their presenteeism
instrument, the VOLP. The VOLP was designed to identify
and measure productivity loss associated with various chronic
health conditions and was validated using a sample of em-
ployees working with rheumatoid arthritis. Zhang et al. state
that the concept of productivity is based on the theory of the
production function, where output is a function of inputs in-
cluding labour, capital and technology. Based on the econom-
ic theory of the production function, the authors define pro-
ductivity loss due to ill health as the output loss associated
with reduced labour input. Zhang et al. highlighted that no
other existing presenteeism instrument captures both time in-
put loss and information about workplace/job characteristics.
The aim of the VOLP is to capture this information so that it
can be used to measure productivity loss in terms of output
loss associated with reduced labour input caused by ill health.
Zhang et al. also critiqued the economics of valuing
presenteeism using wage rates. Economic theory states that
wages are assumed to be equal to the marginal productivity
of workers. However, Zhang et al. argued that wages are often
not an accurate reflection of the true value of productivity at
the margin because of various other factors such as team pro-
duction, availability of perfect substitutes and time sensitivity
of outputs. Zhang et al. argue that these workplace and job
characteristics need to be taken into account explicitly when
attempting to measure productivity loss caused by ill health.
The remaining 23 studies stated that the motivation for the
development of their presenteeism instruments was based on
(1) the need to estimate the impact of presenteeism suitable for
economic evaluations of healthcare and workplace interven-
tions (18 studies: [22, 24, 25, 28–33, 35–42, 43•, 45]) and (2)
the need to estimate individuals’ ability to function at work (5
studies: [23, 26, 27, 34, 44]). No formal theoretical framework
of presenteeism from an economic or other relevant discipline,
for example psychology, was used to underpin the methods
used by the remaining 24 presenteeism instruments.
Fig. 1 Flow diagram of study
selection process
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Discussion
This systematic review has identified a substantial number of
self-report presenteeism instruments, and one of these was
specifically designed for use in an MSD-related condition
(RA). With one exception, the development of the existing
instruments was not underpinned by economic theory.
Currently, the majority of self-reported instruments are atheo-
retical, which is problematic because the rationale, construct
and development of the instruments cannot be linked. Zhang
et al. [43•] was the only study that described how the econom-
ic theory of productivity was used to inform the design of the
VOLP. The advantage of underpinning the design of the
VOLP with economic theory of productivity is that it is clear
what the rationale of the VOLP was, how it was designed and
how it should be interpreted and used. Zhang et al. [43•] argue
that most presenteeism instruments in the literature focus on
measuring an individual’s labour input by measuring the time
spent not working rather than the output lost from reduced
labour. It is clear that in the absence of an economic theory
of presenteeism, the interpretation of presenteeism from an
economic viewpoint is contentious.
The absence of economic theory used to support the
instrument to identify and measure presenteeism may
have also contributed to the way in which researchers
have approached the development of presenteeism instru-
ments. The lack of a theoretical model for presenteeism
means that researchers do not have a common framework
from which to begin their research and develop their
ideas. Therefore, as research into the measurement of
presenteeism has grown, the instruments developed to
quantify presenteeism have become more differentiated
and more complex. The presenteeism instruments devel-
oped in the 1980s and 1990s are relatively simple where
the respondent is asked to give information about their
perceived level of absenteeism and presenteeism based
on their health condit ion. In comparison, those
presenteeism instruments developed in the late 2000s
ask the respondent to consider a wide range of factors
including job characteristics, team dynamics, time-
sensitive output, job satisfaction, job security and rela-
tionships with colleagues, as well as the direct impact
on presenteeism caused by their health condition. Ospina
et al. [21•] and Noben et al. [47] recommended that the
development of more self-reported presenteeism instru-
ments is not needed and instead the literature should focus
their effort on improving the ones that already exist. To
some extent, this is happening where the two latest
presenteeism instruments, the composite work functioning
approach and the iPCQ, use questions from pre-existing
presenteeism instruments. However, it is not yet clear
which instruments are the most appropriate for measuring
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general, and MSD, specifically. The OMERACT group
are currently working towards recommending which of
the available measures is best used in the context of rheu-
matoid arthritis [48]. However, taking into account eco-
nomic theory suggests the need to define the best measure
in terms of clearly specifying the three constituent parts
(identification, measurement, valuation) to quantify the
impact of presenteeism.
Limitations
The studies that were used to identify whether or not
presenteeism instruments were developed using economic
theory did not provide extensive detail. Many studies provid-
ed limited information that described how the presenteeism
instrument was created. In an area where the quantification
of a concept is subjective, such as presenteeism, it should be
encouraged that researchers publish information about the
conceptualisation and development of their presenteeism in-
strument. Such information would help inform the correct
application and interpretation of their instrument, especially
in the absence of applying an economic framework from
which to underpin the instrument.
Conclusions
This review has systematically identified all self-reported
presenteeism instruments, providing a historical context
and whether presenteeism instruments are underpinned
by economic theory. With the exception of the VOLP,
none of the instruments are explicitly underpinned by eco-
nomic theory. One key area for further research is to take
account of the need to understand how to identify, quan-
tify and value the impact of presenteeism, while underpin-
ning these stages with relevant economic theory for each
constituent part of this process. Economic theory would
aid the correct interpretation and application of the self-
report presenteeism instrument and valuation approach. It
is also vital that further development of presenteeism in-
struments are informed by robust empirical studies that
take account of the context in which the final instrument
will be used.
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Appendix. Electronic search strategies
OVID databases:
Medline (1946 to September week 3 2015),
Embase (1980 to week 40 2015),
CENTRAL (August 2015)
PsycINFO (1806 to September week 4 2015)
1. American Productivity Audit.tw.
2. “angina-related limitations at work question?aire”.tw.
3. endicott work productivity scale.tw.
4. “health and labo?r question?aire”.tw.
5. “health and performance question?aire”.tw.
6. “health and productivity question?aire”.tw.
7. “health and work question?aire”.tw.
8. health-related productivity question?aire*.tw.
9. “lam employment absence and productivity scale”.tw.
10. (migraine disability assessment adj2 (question?aire or survey or
scale or score*)).tw.
11. MIDAS.tw. and migraine*.mp.
12. 10 or 11
13. (productiv* or presenteeism or absenteeism or work* or
employ*).mp.
14. 12 and 13
15. “migraine work and productivity loss question?aire”.tw.
16. (osterhaus and (work* or productivity or presenteeism)).tw.
17. (osterhaus adj3 technique).tw.
18. “productivity and disease question?aire”.tw.
19. PRODISQ.tw.
20. (quantity adj2 quality adj (method or instrument)).tw.
21. (Stanford* adj5 Presenteeism Scale).tw.
22. “work and health interview”.tw.
23. work performance scale.tw.
24. “work productivity and activity impairment*”.tw.
25. WPAI*.tw.
26. (US National Health and Wellness Survey).tw. and (productiv* or
presenteeism or absenteeism or work*).mp.
27. “health and work performance question?aire”.tw.
28. work productivity short inventory.tw.
29. wellness inventory.tw.
30. work role functioning question?aire.tw.
31. (or/1–9) or (or/14–30)
32. limit 31 to english language
33. (work productivity survey or WPS-RA).tw.
34. valuation of lost productivity.tw.
35. work limitations question?aire.tw.
36. (33 or 34) not 32
37. limit 36 to english language
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38. 35 not 32
39. limit 38 to english language
40. 32 or 37
41. 32 or 37 or 39
ISI platform databases:
Web of Science (1900–November 6, 2015)
# 1 TS=“angina-related limitations at work questionnaire”
# 2 ( (TS=“end i co t t wo rk p roduc t i v i t y s ca l e” ) ) AND
Language=(English)
# 3 (TS=(“health and labor questionnaire”OR “health and labour ques-
tionnaire”)) AND Language=(English)
# 4 ((TS=“health and productivity questionnaire”)) AND
Language=(English)
# 5 . ( ( TS= “h e a l t h a nd wo r k qu e s t i o nn a i r e ” ) ) AND
Language=(English)
# 6. ((TS=“health-related productivity questionnaire”)) AND
Language=(English)
# 7. ((TS=“lam employment absence and productivity scale”)) AND
Language=(English)
# 8. 8 ((TS=“migraine work and productivity loss questionnaire”))
AND Language=(English)
# 9. ((TS=“Stanford Presenteeism Scale”)) AND Language=(English)
# 10. ((TS=“health and work performance questionnaire”)) AND
Language=(English)
# 11. ((TS=“work and health interview”)) AND Language=(English)
# 12. ((TS=“work performance scale”)) AND Language=(English)
# 13. ((TS=“work productivity short inventory”)) AND
Language=(English)
# 14 . ( ( TS= “Ame r i c a n P r o du c t i v i t y Aud i t ” ) ) AND
Language=(English)
# 15. ((TS=(osterhaus and (work or productivity)))) AND
Language=(English)
# 16. TS=(“work productivity and activity impairment*”)
# 17. TS=WPAI*
# 18. TS=“wellness inventory”
# 19. TS=(“work productivity survey”)
# 20. TS=(“Work role functioning*” SAME limitations)
# 21. TS=(osterhaus SAME technique)
# 22. TS=(“productivity and disease questionnaire”)
# 23. (TS=(migraine disability assessment SAME (score* OR scale
OR questionnaire OR survey))) AND Language=(English)
# 24. (TS=(MIDAS AND migraine)) AND Language=(English)
# 25. (TS=Osterhaus) AND Language=(English)
# 26. (#23 OR #24 OR #25) AND Language=(English)
# 27. (TS = (work* or productivity or performance or
presenteeism or absenteeism or employ*)) AND
Language=(English)
# 28. (#26 AND #27) AND Language=(English)
# 29. (TS=(“work role functioning questionnaire”)) AND
Language=(English)
# 30. (TS=“health and performance questionnaire”) AND
Language=(English)
# 31. TS=(“valuation of lost productivity”)
# 32. TS=(“work limitations questionnaire”)
# 33. (#1 OR #2OR #3OR #4OR #5OR #6OR #7OR #8OR #9OR
#10 OR #11 OR #12 OR #13 OR #14 OR #15 OR #16 OR #17
OR #18 OR #19 OR #20 OR #21 OR #22 OR #28 OR #29 OR
#30 OR #31 OR #32) AND Language=(English)
EBSCO databases:
CINAHL (1937–November 6, 2015)
Business Source Complete (1886–November 6, 2015)
Proquest databases:
ABI Inform (1970–November 6, 2015)
ALL ((“American Productivity Audit”) OR (“angina-related lim-
itations at work questionnaire”) OR (“endicott work productivity
scale”) OR (“health and labor questionnaire”) OR (“health and la-
bour questionnaire”) OR (“health and productivity questionnaire”)
OR (“health and work questionnaire”) OR (“health and performance
questionnaire”) OR (“health-related productivity questionnaire”) OR
(“lam employment absence and productivity scale”) OR (“migraine




S28 S1 or S2 or S3 or S4 or S5 or S6 or S7 or S8 or S9 or S10 or
S11 or S12 or S13 or S14 or S15 or S16 or S17 or S18 or
S19 or S20 or S21 or S22 or S23 or S24 or S25
S25 “work limitations questionnaire”
S24 “valuation of lost productivity”
S23 “work productivity survey”
S22 “health and performance questionnaire”
S21 “productivity and disease questionnaire“
S20 osterhaus AND (technique or presenteeism or absenteeism or
productivity or work* or employ*)
S19 “Work role functioning questionnaire”
S18 “wellness inventory”
S17 WPAI*
S16 “work productivity and activity impairment*”
S15 “American Productivity Audit”
S14 “work productivity short inventory”
S13 “work performance scale”
S12 “work and health interview”
S11 “health and work performance questionnaire”
S10 “Stanford Presenteeism Scale”
S9 “migraine work and productivity loss questionnaire”
S8 “lam employment absence and productivity scale”
S7 ((“migraine disability assessment” n2 (score* or scale or
survey or questionnaire)) OR (MIDAS AND migraine))
AND (work* OR productivity OR presenteeism OR
absenteeism OR employ*)
S6 “health-related productivity questionnaire”
S5 “health and work questionnaire”
S4 “health and productivity questionnaire”
S3 (“health and labor questionnaire”) OR (“health and labour
questionnaire”)
S2 “endicott work productivity scale”
S1 “angina-related limitations at work questionnaire”
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Presenteeism Scale”) OR (“work performance scale”) OR (“work
and health interview”) OR (“health and work performance question-
naire”) OR (“productivity and disease questionnaire”) OR WPAI*
OR (“work productivity and activity impairment*”) OR (“work pro-
ductivity short inventory”) OR (“wellness inventory”) OR (“work
role functioning questionnaire”) OR (“valuation of lost productivi-
ty”) OR (“work productivity survey”) OR (“work limitations ques-
tionnaire”) OR (((“migraine disability assessment questionnaire”)
OR (MIDAS AND migraine) OR Osterhaus) AND (productivity or
presenteeism or work* or employ*))
Open Access This article is distributed under the terms of the Creative
Commons At t r ibut ion 4 .0 In te rna t ional License (h t tp : / /
creativecommons.org/licenses/by/4.0/), which permits unrestricted use,
distribution, and reproduction in any medium, provided you give appro-
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